These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 16604476)
41. Influence of sentinel lymph node tumor burden on survival in melanoma. Francischetto T; Spector N; Neto Rezende JF; de Azevedo Antunes M; de Oliveira Romano S; Small IA; Gil Ferreira C Ann Surg Oncol; 2010 Apr; 17(4):1152-8. PubMed ID: 20087785 [TBL] [Abstract][Full Text] [Related]
42. Results of sentinel lymph node biopsy in patients with thin melanoma. Wong SL; Brady MS; Busam KJ; Coit DG Ann Surg Oncol; 2006 Mar; 13(3):302-9. PubMed ID: 16485151 [TBL] [Abstract][Full Text] [Related]
43. Patterns of drainage and recurrence following sentinel lymph node biopsy for cutaneous melanoma of the head and neck. Fincher TR; O'Brien JC; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; Kuhn JA Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):844-8. PubMed ID: 15262761 [TBL] [Abstract][Full Text] [Related]
44. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative. Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204 [TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ghaferi AA; Wong SL; Johnson TM; Lowe L; Chang AE; Cimmino VM; Bradford CR; Rees RS; Sabel MS Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133 [TBL] [Abstract][Full Text] [Related]
46. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Caracò C; Marone U; Celentano E; Botti G; Mozzillo N Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345 [TBL] [Abstract][Full Text] [Related]
48. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma. Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245 [TBL] [Abstract][Full Text] [Related]
49. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Leong SP; Accortt NA; Essner R; Ross M; Gershenwald JE; Pockaj B; Hoekstra HJ; Garberoglio C; White RL; Chu D; Biel M; Charney K; Wanebo H; Avisar E; Vetto J; Soong SJ; Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):370-3. PubMed ID: 16618904 [TBL] [Abstract][Full Text] [Related]
50. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134 [TBL] [Abstract][Full Text] [Related]
51. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004. Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331 [TBL] [Abstract][Full Text] [Related]
52. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169 [TBL] [Abstract][Full Text] [Related]
53. [Prognosis after sentinel node biopsy in malignant melanoma]. Lock-Andersen J; Horn J; Sjøstrand H Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370 [TBL] [Abstract][Full Text] [Related]
54. [Sentinel lymph node biopsy in patients with cutaneous malignant melanoma]. Gad D; Sjøgren P Ugeskr Laeger; 2003 Jun; 165(25):2567-70. PubMed ID: 12854268 [TBL] [Abstract][Full Text] [Related]
55. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Scheri RP; Essner R; Turner RR; Ye X; Morton DL Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497 [TBL] [Abstract][Full Text] [Related]
56. Reevaluation of the locoregional recurrence rate in melanoma patients with a positive sentinel node compared to patients with palpable nodal involvement. Veenstra HJ; van der Ploeg IM; Wouters MW; Kroon BB; Nieweg OE Ann Surg Oncol; 2010 Feb; 17(2):521-6. PubMed ID: 19898903 [TBL] [Abstract][Full Text] [Related]
57. Melanoma of the ear: prognostic factors and surgical strategies. Jahn V; Breuninger H; Garbe C; Moehrle M Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802 [TBL] [Abstract][Full Text] [Related]
58. Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node? Satzger I; Meier A; Zapf A; Niebuhr M; Kapp A; Gutzmer R Melanoma Res; 2014 Oct; 24(5):454-61. PubMed ID: 24811213 [TBL] [Abstract][Full Text] [Related]
59. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721 [TBL] [Abstract][Full Text] [Related]
60. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma. Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]